[
  {
    "statement": "21. Midline catheter tip position and catheter-related complications in antimicrobial therapy: A multi-center randomized controlled trial. Values highlighted: Reduced Complications | First-Attempt Insertion | Longer Dwell Time | Stability\n(Zhao L et al. Int J Nurs Stud. 2023)\nStudy author(s)\nZhao L, Fan X, Zhao L, et al.\nStudy design (level of evidence)\nRandomized controlled trial (Level 2)\nStudy objective\n5\nTo provide evidence for selecting MC tip\npositions for safe use in antimicrobial\ntherapy.\nPublication\nInt J Nurs Stud. 2023\nDOI: 10.1016/j.ijnurstu.2023.104476\nStudy location\nChina\nStudy Length\n5 months (September 2020 - January 2021)",
    "reference_no": "21",
    "reference": "",
    "page_no": 1
  },
  {
    "statement": "Study protocol. Evaluation indicators and judgment criteria were\nincidence of catheter-related complications and\nindwelling catheter duration.",
    "reference_no": "10",
    "reference": "",
    "page_no": 2
  },
  {
    "statement": "Study findings. Longest dwell time recorded was of 131 days.",
    "reference_no": "3",
    "reference": "",
    "page_no": 4
  },
  {
    "statement": "Study findings. MC tips placed in the subclavian or axillary vein of the chest wall had the lowest complication rates.",
    "reference_no": "8",
    "reference": "",
    "page_no": 4
  },
  {
    "statement": "Study findings. Placing midline catheter tips in the subclavian or axillary vein significantly reduces catheter-\nrelated complications during antimicrobial therapy.",
    "reference_no": "6",
    "reference": "",
    "page_no": 4
  },
  {
    "statement": "22. Comparing incidence of thrombosis in PICC and midlines and evaluating the role of anticoagulation, site of insertion, and risk factors. Values highlighted : Reduced Complications\n(Zohourian H et al. J Assoc Vasc Access. 2019)\nStudy author(s)\nZohourian H, Schaubschlager T, Phan L,\net al.\nStudy design (level of evidence)\nRetrospective cohort study (Level\nStudy objective\nTo evaluate previously proposed risk factors\nassociated with increased rate of CT and to\nform an objective clinical prediction score to\naid clinicians in distinguishing high-risk\npatients.\nPublication\nJ Assoc Vasc Access. 2019\nDOI: 10.1016/j.java.2018.29.004\nStudy location\nUnited States\nStudy Length\n1 year (January 1, 2016 - December 31, 2016)",
    "reference_no": "22",
    "reference": "",
    "page_no": 6
  },
  {
    "statement": "Study protocol. Inclusion criteria: Adult patients who underwent\neither a PICC or midline catheter placement\nbetween January 1 and December 31, 2016.",
    "reference_no": "2",
    "reference": "",
    "page_no": 7
  },
  {
    "statement": "Study protocol. The means or frequencies of potential catheter-\nrelated thrombosis (CT) risk factors were compared\nbetween cases and controls.",
    "reference_no": "6",
    "reference": "",
    "page_no": 7
  },
  {
    "statement": "Study findings. The insertion site, whether basilic, brachial, or cephalic vein, did not significantly affect the risk of thrombosis.",
    "reference_no": "2",
    "reference": "",
    "page_no": 9
  },
  {
    "statement": "Study findings. Prophylactic anticoagulation showed reduced CT trend but was not statistically significant.",
    "reference_no": "4",
    "reference": "",
    "page_no": 9
  },
  {
    "statement": "Study findings. Identified risk factors are associated with increased rate of thrombosis. A clinical prediction score\ncan objectively identify high risk patients. There was no statistical difference in thrombosis event\nbetween vein insertion sites or use of prophylactic anticoagulation.",
    "reference_no": "5",
    "reference": "",
    "page_no": 9
  },
  {
    "statement": "Study findings. Midline catheters demonstrated a slightly lower, though not statistically significant,\nincidence of thrombosis compared to PICCs, with several patient and device factors\ninfluencing CT risk.",
    "reference_no": "6",
    "reference": "",
    "page_no": 9
  },
  {
    "statement": "23. Midline venous catheters as an alternative to central line catheter placement: a product evaluation. Values highlighted : Reduced Complications | First-Attempt Insertion | Longer Dwell Time | Stability|\nCost Effective\n(Car A et al. Br J Nurs. 2021)\nStudy author(s)\nCarr A, Green JR, Benish E, et al.\n3\nStudy design (level of evidence)\nProspective observational study\n(Level 3)\nStudy objective\nTo evaluate the clinical performance of the\nPowerwand® midline catheter\nPublication\nBr J Nurs. 2021\nDOI: 10.12968/bjon.2021.30.8.S10\nStudy location\nUnited States\nStudy Length\n4 months (September 2018 - December 2018)",
    "reference_no": "23",
    "reference": "",
    "page_no": 11
  },
  {
    "statement": "Study protocol. In infants, the Powerwand was typically inserted in\nthe lower leg or upper arm, while in toddlers and\nolder children, it was placed in the forearm or upper\narm.",
    "reference_no": "®",
    "reference": "",
    "page_no": 12
  },
  {
    "statement": "Study findings. Patients were spared an average of 12 vascular access attempts, during their hospitalization, when\nPowerwand was used.",
    "reference_no": "®",
    "reference": "",
    "page_no": 13
  },
  {
    "statement": "Study findings. On average, the use of these catheters prevented average 6.1 PVC reinsertions and 6.3 blood draw sticks per\npatient. In terms of cost, each Powerwand catheter cost $170.25, compared to $32.55 per PVC. This resulted\nin an overall cost saving of $2,892.45 due to the reduction in PVC use.",
    "reference_no": "®",
    "reference": "",
    "page_no": 13
  },
  {
    "statement": "Study findings. Midline catheters are becoming more prevalent in both inpatient and outpatient settings.",
    "reference_no": "6",
    "reference": "",
    "page_no": 13
  },
  {
    "statement": "Study findings. The Powerwand midline catheter offers a safe, durable, and cost-effective alternative to\nCVCs and PVCs, reducing complications and improving vascular access outcomes across\npatient populations.",
    "reference_no": "®",
    "reference": "",
    "page_no": 13
  },
  {
    "statement": "24. Optimizing vascular-access device decision-making in the era of midline catheters. Values highlighted: Reduced Complications | Longer Dwell Time | Stability| Cost Effective\n(Cawcutt KA et al. Infect Control Hosp Epidemiol. 2019)\nStudy author(s)\nCawcutt KA, Hankins RJ, Micheels TA,\net al.\nPublication\nInfect Control Hosp Epidemiol. 2019\nDOI: 10.12968/bjon.2021.30.8.S10\nStudy design (level of evidence)\nNarrative review (Level 6)\nStudy objective\nTo guide clinicians in selecting the most\nappropriate vascular access device (VAD)\nand to address risks, benefits, and\ncomplications associated with various VADs.\nStudy location\nUnited States\nStudy Length\nNA",
    "reference_no": "24",
    "reference": "",
    "page_no": 15
  },
  {
    "statement": "Study findings. Midlines are appropriate for medium-term therapy (typically up to 4 weeks).",
    "reference_no": "1",
    "reference": "",
    "page_no": 17
  },
  {
    "statement": "Study findings. Midlines do not reach central veins, reducing risk of pneumothorax, cardiac arrhythmias, and central venous\nstenosis.",
    "reference_no": "3",
    "reference": "",
    "page_no": 17
  },
  {
    "statement": "Study findings. Vancomycin and other medications previously considered vesicants are increasingly safe via midline.",
    "reference_no": "4",
    "reference": "",
    "page_no": 17
  },
  {
    "statement": "Study findings. Midline programs are associated with reduced CLABSI rates and cost.",
    "reference_no": "5",
    "reference": "",
    "page_no": 17
  },
  {
    "statement": "Study findings. Mechanical complications (e.g., pain, edema, occlusion) occur at rates between 2.6%–11.5%.",
    "reference_no": "6",
    "reference": "",
    "page_no": 17
  },
  {
    "statement": "Study findings. Thrombosis risk is generally lower than PICCs, especially in non-ICU settings.",
    "reference_no": "7",
    "reference": "",
    "page_no": 17
  },
  {
    "statement": "Study findings. Patient satisfaction is improved by fewer needlesticks and lower complication rates.",
    "reference_no": "9",
    "reference": "",
    "page_no": 17
  },
  {
    "statement": "Study findings. Midline catheters offer a safe, cost-effective alternative to central lines for medium-term\ntherapy, with fewer complications and strong support for broader use in clinical decision-\nmaking.",
    "reference_no": "8",
    "reference": "",
    "page_no": 17
  },
  {
    "statement": "25. Recommendations for the use of vascular access in the COVID-19 patients: an Italian perspective. Values highlighted: Reduced Complications | Longer Dwell Time | Stability| Cost Effective\n(Pittiruti M et al. Crit Care. 2020)\nStudy author(s)\nPittiruti M, Pinelli F\nPublication\nCrit Care. 2020\nDOI: 10.1186/s13054-020-02997-1\nStudy design (level of evidence)\nConsensus recommendations (Level\n6)\nStudy objective\nTo recommend safe and effective vascular\naccess strategies for COVID-19 patients.\nStudy location\nItaly\nStudy Length\nNA",
    "reference_no": "25",
    "reference": "",
    "page_no": 19
  },
  {
    "statement": "Study findings. Midline catheters and mini-midlines are recommended for non-ICU COVID-19 patients over short peripheral\ncannulas.",
    "reference_no": "2",
    "reference": "",
    "page_no": 21
  },
  {
    "statement": "Study findings. Ultrasound-guided insertion is strongly recommended for midlines.",
    "reference_no": "4",
    "reference": "",
    "page_no": 21
  },
  {
    "statement": "Study findings. No radiologic confirmation is needed for tip placement in midlines",
    "reference_no": "5",
    "reference": "",
    "page_no": 21
  },
  {
    "statement": "Study findings. Emphasis on infection control, anticoagulation protocols, and operator safety during insertion and\nmaintenance.",
    "reference_no": "8",
    "reference": "",
    "page_no": 21
  }
]